Trials / Completed
CompletedNCT04775017
Delirium in Covid-19: Germany-wide Covid-19 Intensive Register
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,398 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.
Conditions
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-02-21
- Completion
- 2022-08-31
- First posted
- 2021-03-01
- Last updated
- 2024-10-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04775017. Inclusion in this directory is not an endorsement.